Coupling between two Ru(bda) catalysts bridged by a trans-dicyano complex.

We have prepared two trimetallic complexes [{Ru(bda)(DMSO)(µ-CN)}2Ru(L)4] (with bda = 2,2'-bipyridine-6,6'-dicarboxylate) where two {Ru(bda)} centers are bridged by a cyanide complex of the trans-Ru(L)4CN2 family (with L = pyridine and 4-tert-butylpyridine). The complex [{Ru(bda)(DMSO)(µ-CN)}2Ru(py)4] is fully soluble in aqueous solution and is a catalyst for the oxidation of water both chemically, using Ce(IV) at pH = 1 as the terminal oxidant, and electrochemically. Both reactions are first order in the complex and the resting state of the catalyst is the [RuVRuIII(py)4RuIV]2+ redox state. Electrochemical and spectroelectrochemical studies together with (TD)DFT calculations show that the coupling between the Ru(bda) fragments for the [RuIIIRuII(py)4RuIII]2+ and [RuIVRuII(py)4RuIV]2+ redox states is very weak, but significant for the [RuVRuII(py)4RuIV]2+ ion due to the orientation of the orbitals involved. This coupling affects the reactivity of the [RuVRuII(py)4RuIV]2+ redox state, making it a much slower catalyst towards the water oxidation reaction than [RuVRuIII(py)4RuIV]2+.

Oxidative stress and mitochondrial adaptive shift during pituitary tumoral growth.

The cellular transformation of normal functional cells to neoplastic ones implies alterations in the cellular metabolism and mitochondrial function in order to provide the bioenergetics and growth requirements for tumour growth progression. Currently, the mitochondrial physiology and dynamic shift during pituitary tumour development are not well understood. Pituitary tumours present endocrine neoplastic benign growth which, in previous reports, we had shown that in addition to increased proliferation, these tumours were also characterized by cellular senescence signs with no indication of apoptosis. Here, we show clear evidence of oxidative stress in pituitary cells, accompanied by bigger and round mitochondria during tumour development, associated with augmented biogenesis and an increased fusion process. An activation of the Nrf2 stress response pathway together with the attenuation of the oxidative damage signs occurring during tumour development were also observed which will probably provide survival advantages to the pituitary cells. These neoplasms also presented a progressive increase in lactate production, suggesting a metabolic shift towards glycolysis metabolism. These findings might imply an oxidative stress state that could impact on the pathogenesis of pituitary tumours. These data may also reflect that pituitary cells can modulate their metabolism to adapt to different energy requirements and signalling events in a pathophysiological situation to obtain protection from damage and enhance their survival chances. Thus, we suggest that mitochondria function, oxidative stress or damage might play a critical role in pituitary tumour progression.